Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
Clinical trial NCT04295551 · UNKNOWN
Trial details
- NCT number
- NCT04295551
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-14
- Primary completion
- 2020-07-14
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.